"Blood Glucose" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glucose in blood.
Descriptor ID |
D001786
|
MeSH Number(s) |
D09.947.875.359.448.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Blood Glucose".
Below are MeSH descriptors whose meaning is more specific than "Blood Glucose".
This graph shows the total number of publications written about "Blood Glucose" by people in this website by year, and whether "Blood Glucose" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 2 | 3 |
1996 | 1 | 2 | 3 |
1997 | 1 | 1 | 2 |
1998 | 0 | 5 | 5 |
1999 | 2 | 1 | 3 |
2000 | 1 | 1 | 2 |
2001 | 4 | 0 | 4 |
2002 | 1 | 4 | 5 |
2003 | 4 | 2 | 6 |
2004 | 3 | 3 | 6 |
2005 | 1 | 7 | 8 |
2006 | 6 | 7 | 13 |
2007 | 3 | 3 | 6 |
2008 | 6 | 6 | 12 |
2009 | 8 | 7 | 15 |
2010 | 3 | 8 | 11 |
2011 | 4 | 3 | 7 |
2012 | 2 | 8 | 10 |
2013 | 10 | 12 | 22 |
2014 | 9 | 9 | 18 |
2015 | 1 | 7 | 8 |
2016 | 7 | 7 | 14 |
2017 | 4 | 5 | 9 |
2018 | 4 | 4 | 8 |
2019 | 6 | 5 | 11 |
2020 | 3 | 3 | 6 |
2021 | 1 | 4 | 5 |
2022 | 0 | 5 | 5 |
2023 | 1 | 7 | 8 |
2024 | 1 | 4 | 5 |
2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Blood Glucose" by people in Profiles.
-
Early Postpartum Metabolic Heterogeneity Among Women Who Progressed to Type 2 Diabetes After Gestational Diabetes: A Prospective Cohort. Diabetes Metab Res Rev. 2025 Jan; 41(1):e70027.
-
The sleep for health study: A randomized clinical trial of the impact of insomnia treatment on glycemia in people with prediabetes. Contemp Clin Trials. 2025 Feb; 149:107796.
-
Risk of Infection in Older Adults With Type 2 Diabetes With Relaxed Glycemic Control. Diabetes Care. 2024 Dec 01; 47(12):2258-2265.
-
Prediction of pancreatic cancer in patients with new onset hyperglycemia: A modified ENDPAC model. Pancreatology. 2024 Nov; 24(7):1115-1122.
-
Cardiovascular and mortality benefits of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists as third-step glucose-lowering medicine in patients with type 2 diabetes: a retrospective cohort analysis. BMJ Open Diabetes Res Care. 2024 May 06; 12(3).
-
Racial differences in measures of glycemia in the Vitamin D and Type 2 Diabetes (D2d) Study: a secondary analysis of a randomized trial. BMJ Open Diabetes Res Care. 2024 Feb 12; 12(1).
-
Heterogeneous Treatment Effects of Intensive Glycemic Control on Kidney Microvascular Outcomes and Mortality in ACCORD. J Am Soc Nephrol. 2024 02 01; 35(2):216-228.
-
Racial and Ethnic Differences in the Association Between Mean Glucose and Hemoglobin A1c. Diabetes Technol Ther. 2023 Oct; 25(10):697-704.
-
A pre-conception clinical trial to reduce intergenerational obesity and diabetes risks: The NDPP-NextGen trial protocol. Contemp Clin Trials. 2023 10; 133:107305.
-
Effect of vitamin D on regression to normal glucose regulation and individual glycemic measures: A secondary analysis among participants adherent to the trial protocol in the randomized clinical trial vitamin D and type 2 diabetes (D2d) study. Diabetes Res Clin Pract. 2023 Aug; 202:110792.